Health Catalyst Sees Prelim. Q3 Total Revenue $73.8M vs $72.66M Est.; Sees FY23 Revenue $291M-$296M vs $293.78M Est.
Portfolio Pulse from Benzinga Newsdesk
Health Catalyst has released its preliminary Q3 total revenue, which is $73.8M, surpassing the estimated $72.66M. The company also projects its FY23 revenue to be between $291M and $296M, compared to the estimated $293.78M.
October 27, 2023 | 12:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Health Catalyst's Q3 revenue exceeded estimates and its FY23 revenue forecast is in line with expectations. This could positively impact the company's stock.
Health Catalyst's Q3 revenue beat estimates, which is generally seen as a positive sign by investors. Additionally, the company's FY23 revenue forecast is in line with estimates, indicating that the company is performing as expected. This could lead to increased investor confidence and a potential rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100